A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.

NCT07567781 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: ABBV-722
DRUG: Midazolam
DRUG: Metformin
DRUG: Digoxin
DRUG: Pitavastatin
DRUG: Sitagliptin

Sponsor

AbbVie